Acquisition focused on clinical-stage program potravitug, a first-in-class BK polyomavirus monoclonal antibody Totality of evidence from the ...

Important international recognition for the Federico II University Hospital of Naples, awarded for clinical and scientific ...

A Dallas medical assistant program is trying to solve workforce training challenges by involving employers before graduation.

Oversubscribed $225 million concurrent private investment in public equity ("PIPE") with available cash to the combined ...

FDA proof-of-concept trials with AstraZeneca and Amgen validate continuous data transmission and signal detection, setting ...

IND authorization paves the way for initiation of GT-02287 Phase 2 clinical development in the U.S., expected during 3Q26FDA’s decision follows ...

Highly sensitive next-generation sequencing-based MRD testing will identify eligible patients with T-cell malignancies ...

Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical ...

After a double whammy blow, Cynata is “actively reviewing” alternative uses for its Cymerus platform technology. ... Read ...

Selecting a compliance officer is one of the most consequential hiring decisions a health care organization can make. In an industry subject to ...

Older adults and working-age people whose atrial fibrillation is caught through screening, rather than through symptoms or ...

FRONT-2 global enrollment completed approximately 4 months ahead of initial projections4FRONT-2 over-enrolled (anticipated N>500), with final patient randomization expected in Q3 2026, reflecting stro ...